Nautilus Biotechnology, INC. (NAUT) — 8-K Filings

All 8-K filings from Nautilus Biotechnology, INC.. Browse 6 Current Event Report reports with AI-powered summaries and risk analysis.

8-K Filings (6)

Nautilus Biotechnology Files 8-K Under 'Other Events' — Nov 4, 2025 Risk: low
Nautilus Biotechnology, Inc. filed an 8-K on November 4, 2025, reporting an event that occurred on November 3, 2025. The filing is categorized under 'Other Even
Nautilus Biotechnology Files 8-K on Shareholder Vote — Jun 23, 2025 Risk: low
Nautilus Biotechnology, Inc. filed an 8-K on June 23, 2025, reporting on matters submitted to a vote of security holders on June 20, 2025. The company, formerly
Nautilus Biotechnology Faces Delisting Concerns — May 2, 2025 Risk: high
Nautilus Biotechnology, Inc. filed an 8-K on May 1, 2025, to report a notice of delisting or failure to satisfy a continued listing rule. The company was former
Nautilus Biotechnology Announces Board and Executive Changes — Jan 31, 2025 Risk: medium
Nautilus Biotechnology, Inc. announced on January 27, 2025, changes in its board of directors and executive compensation. Specifically, the company reported the
Nautilus Biotechnology Files 8-K on Shareholder Vote Matters — Jun 13, 2024 Risk: medium
Nautilus Biotechnology, Inc. filed an 8-K on June 13, 2024, to report on matters submitted to a vote of its security holders. The filing indicates a change in t
Nautilus Biotechnology Enters Material Definitive Agreement — Feb 28, 2024 Risk: medium
Nautilus Biotechnology, Inc. filed an 8-K on February 28, 2024, to report an entry into a material definitive agreement. The filing indicates that the company,

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX